CA2485223A1 - Active complex of alpha-lactalbumin (hamlet) and cofactor - Google Patents

Active complex of alpha-lactalbumin (hamlet) and cofactor Download PDF

Info

Publication number
CA2485223A1
CA2485223A1 CA002485223A CA2485223A CA2485223A1 CA 2485223 A1 CA2485223 A1 CA 2485223A1 CA 002485223 A CA002485223 A CA 002485223A CA 2485223 A CA2485223 A CA 2485223A CA 2485223 A1 CA2485223 A1 CA 2485223A1
Authority
CA
Canada
Prior art keywords
lactalbumin
alpha
biologically active
use according
hamlet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002485223A
Other languages
English (en)
French (fr)
Inventor
Catharina Svanborg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nya HAMLET Pharma AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2485223A1 publication Critical patent/CA2485223A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
CA002485223A 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor Abandoned CA2485223A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0210464.4 2002-05-08
GBGB0210464.4A GB0210464D0 (en) 2002-05-08 2002-05-08 Therapeutic treatment
PCT/IB2003/002366 WO2003095490A1 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor

Publications (1)

Publication Number Publication Date
CA2485223A1 true CA2485223A1 (en) 2003-11-20

Family

ID=9936230

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002485223A Abandoned CA2485223A1 (en) 2002-05-08 2003-05-08 Active complex of alpha-lactalbumin (hamlet) and cofactor

Country Status (8)

Country Link
US (2) US7270822B2 (enExample)
EP (1) EP1506233B8 (enExample)
JP (1) JP2006500321A (enExample)
AU (1) AU2003233116B2 (enExample)
CA (1) CA2485223A1 (enExample)
DK (1) DK1506233T3 (enExample)
GB (1) GB0210464D0 (enExample)
WO (1) WO2003095490A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
EP1727561A1 (en) * 2004-02-26 2006-12-06 HAMLET Pharma AB Lactalbumin for inhibiting angiogenesis
GB0408752D0 (en) * 2004-04-20 2004-05-26 Hamlet Ltd Therapeutic treatment
EP1715334A1 (fr) * 2005-04-22 2006-10-25 Adamant Technologies SA Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
GB0518720D0 (en) * 2005-09-14 2005-10-19 Hamlet Pharma Ab Therapeutic combination
WO2009135494A2 (en) * 2008-05-09 2009-11-12 Nya Hamlet Pharma Ab Alpha-lactalbumin composition for the treatment of actinic keratosis
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
JP2961625B2 (ja) 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
ATE182470T1 (de) 1994-08-16 1999-08-15 Hemant Sabharwal Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
US6159748A (en) 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
US5614191A (en) * 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
JP2001524491A (ja) 1997-11-21 2001-12-04 カタリーナ・スヴァンボルイ ラクトアルブミン生産方法
GB9725126D0 (en) * 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
EP1311288A1 (en) 2000-01-20 2003-05-21 Ottawa Health Research Institute Immunostimulatory nucleic acids for inducing a th2 immune response
EP1268534A2 (en) 2000-03-24 2003-01-02 Filgen Biosciences, Inc. Peptides binding to non-acetylated h3 and h4 histones for cancer therapy
EP2275557A1 (en) 2000-04-12 2011-01-19 Human Genome Sciences, Inc. Albumin fusion proteins
GB0205347D0 (en) 2002-03-07 2002-04-24 Svanborg Catharina Biologically active complex
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
EP1727561A1 (en) * 2004-02-26 2006-12-06 HAMLET Pharma AB Lactalbumin for inhibiting angiogenesis

Also Published As

Publication number Publication date
EP1506233A1 (en) 2005-02-16
US20060074017A1 (en) 2006-04-06
AU2003233116B2 (en) 2009-03-26
DK1506233T3 (da) 2014-07-07
US20080167233A1 (en) 2008-07-10
EP1506233B8 (en) 2014-09-24
JP2006500321A (ja) 2006-01-05
AU2003233116A1 (en) 2003-11-11
US7270822B2 (en) 2007-09-18
EP1506233B1 (en) 2014-04-02
WO2003095490A1 (en) 2003-11-20
US7713533B2 (en) 2010-05-11
GB0210464D0 (en) 2002-06-12

Similar Documents

Publication Publication Date Title
US7713533B2 (en) Active complex of α-lactalbumin (HAMLET) and cofactor
Redl Human tear lipocalin
JP2023022318A (ja) ペプチドｗｋｄｅａｇｋｐｌｖｋを含む組成物
US20100035819A1 (en) Method of promoting skin collagen production
CN102724954B (zh) 孵化液酶及其用途
JP5679992B2 (ja) 複合体および生産方法
BRPI0721123A2 (pt) Hidrolisatos de proteína do leite com potencial imunogênico reduzido
PT88626B (pt) Processo para a preparacao de um factor de crescimento polipeptidico proveniente de leite
US4342747A (en) Colostrum-based composition for external use
JP4291967B2 (ja) 皮膚コラーゲン産生促進剤
JP2023539476A (ja) アネキシンａ１のｎ末端ペプチド製剤及び方法
EP3142681A1 (en) Peptides and compositions thereof for improvement of glycaemic management in a mammal
RU2445105C2 (ru) Дерматологическое применение молочных белков
BR112021003820A2 (pt) agente para tratamento de distúrbios dermatológicos
JP2005530703A (ja) 生物学的に活性な複合体
TWI863205B (zh) 具傷口癒合功效之鱸魚胜肽及其組成物
JP3815726B2 (ja) 緩衝液からなるローヤルゼリーの鮮度保持剤
WO2016051179A1 (en) Composition comprising lactoferrine and methods of treatment
JP2024532407A (ja) ラクトフェリン組成物及び使用方法
CN118302187A (zh) 乳铁蛋白组合物和使用方法
Harrington Age and cataract-related degradation of crystallins in human lenses
JP2005531539A (ja) ペプチド組成物
JPH07309774A (ja) 抗真菌剤
HK40047629B (zh) 皮肤病治疗剂

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued